MERRIMACK PHARMACEUTICALS IN shareholders Q3 2023

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 65 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.

MERRIMACK PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Western Standard LLC 1,894,013$23,353,18021.09%
Newtyn Management, LLC 1,873,694$23,102,6475.70%
Sio Capital Management, LLC 288,466$3,556,7861.10%
Madison Avenue Partners, LP 553,085$6,819,5380.97%
WITTENBERG INVESTMENT MANAGEMENT, INC. 209,739$2,5860.95%
Indaba Capital Management, L.P. 136,802$1,686,7690.50%
Sepio Capital, LP 306,680$3,781,3640.33%
Yakira Capital Management, Inc. 54,118$667,2750.18%
Centiva Capital, LP 187,803$2,315,6110.05%
FIFTH LANE CAPITAL, LP 10,929$134,4270.05%
KENNEDY CAPITAL MANAGEMENT LLC 93,708$1,155,4200.03%
Mascoma Wealth Management LLC 5,000$61,6500.02%
Caption Management, LLC 100,000$1,233,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 34,200$421,6860.01%
Dorsey Wright & Associates 1,933$23,8340.01%
WEBSTER BANK, N. A. 1,527$18,8280.00%
Rise Advisors, LLC 272$3,3480.00%
Caption Management, LLC 12,200$150,4260.00%
DIMENSIONAL FUND ADVISORS LP 448,752$5,533,1120.00%
Covestor Ltd 87$10.00%
External links

This page lists MERRIMACK PHARMACEUTICALS IN's shareholders in Q3 2023. To view MERRIMACK PHARMACEUTICALS IN's shareholder history, click here.